Treatment of severe Raynaud's syndrome by injection of autologous blood pretreated by heating, ozonation and exposure to ultraviolet light (H-O-U) therapy. [electronic resource]
Producer: 19980528Description: 250-4 p. digitalISSN:- 0392-9590
- 6-Ketoprostaglandin F1 alpha -- blood
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Bacterial Proteins
- Blood -- drug effects
- Blood Flow Velocity
- Blood Transfusion, Autologous -- methods
- Chaperonin 60
- Chaperonins -- blood
- Enzyme-Linked Immunosorbent Assay
- Hot Temperature -- therapeutic use
- Humans
- Laser-Doppler Flowmetry
- Middle Aged
- Ozone -- therapeutic use
- Raynaud Disease -- blood
- Syndrome
- Ultraviolet Rays
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.